Related Experiment Videos
[Contrast medium enhanced MR angiography]
T J Vogl1, Y Hoffmann, A Mühler
1Strahlenklinik und Poliklinik, Universitätsklinikum Rudolph Virchow, Freien Universität Berlin, Standort Wedding.
Abstract:
Magnetic resonance angiography (MRA) protocols are based on standard sequence protocols like time of flight MRA, which evaluates inflowing spins. This technique is limited by a variety of artifacts like the saturation artifact via turbulent blood flow. Contrast media diminish these artifacts like extracellular agents and blood-pool contrast media. The clinical value of the contrast-enhanced MRA for cerebral pathologies is based on the use of the paramagnetic contrast agent Gd-DTPA. For extracerebral diseases this technique is restricted because of the simultaneous visualization of both arterial and venous vascular territories. Occult venous sinus thrombosis or AV malformations are clinical essential indications for the use of C-MRA. Experimental data prove the excellent contrast abilities of blood-pool agents like Gd-DTPA-polylysin or Gd-DTPA-albumin, which demonstrate long intravascular persistence and retarded excretion.
Insights
Contrast-enhanced Magnetic Resonance Angiography (CE-MRA) improves imaging by reducing artifacts. Blood-pool contrast agents offer superior visualization for specific extracerebral vascular conditions.
Area of Science:
- Radiology and Medical Imaging
- Cardiovascular Imaging
- Neuroimaging
Background:
- Standard Magnetic Resonance Angiography (MRA) techniques, such as time-of-flight MRA, are susceptible to artifacts like saturation from turbulent blood flow.
- Contrast media, including extracellular and blood-pool agents, can mitigate these artifacts in MRA.
- Contrast-enhanced MRA (CE-MRA) using Gd-DTPA is valuable for cerebral pathologies but limited for extracerebral diseases due to simultaneous visualization of arterial and venous systems.
Purpose of the Study:
- To evaluate the utility of contrast media in Magnetic Resonance Angiography (MRA).
- To explore the clinical applications of CE-MRA, particularly for extracerebral pathologies.
- To assess the effectiveness of blood-pool contrast agents for enhanced vascular imaging.
Main Methods:
- Review of standard MRA protocols, including time-of-flight MRA.
- Application of contrast media (extracellular agents, blood-pool agents like Gd-DTPA) to reduce MRA artifacts.
- Clinical assessment of CE-MRA for cerebral and extracerebral diseases, focusing on indications like venous sinus thrombosis and AV malformations.
Main Results:
- Contrast media effectively diminish artifacts encountered in standard MRA techniques.
- Gd-DTPA-enhanced MRA is clinically valuable for cerebral pathologies.
- Blood-pool contrast agents (e.g., Gd-DTPA-polylysin, Gd-DTPA-albumin) demonstrate superior contrast and prolonged intravascular persistence, proving effective for extracerebral indications.
Conclusions:
- CE-MRA, especially with advanced blood-pool contrast agents, enhances diagnostic capabilities for specific vascular conditions.
- Blood-pool agents offer improved intravascular persistence and excretion profiles, making them ideal for visualizing extracerebral pathologies like occult venous sinus thrombosis and AV malformations.
- CE-MRA represents a significant advancement in vascular imaging, overcoming limitations of traditional MRA protocols.